- Report
- February 2022
- 55 Pages
United States
From €2164EUR$2,450USD£1,872GBP
- Report
- May 2024
- 65 Pages
Global
From €2164EUR$2,450USD£1,872GBP
- Report
- April 2024
- 91 Pages
Global
From €4372EUR$4,950USD£3,781GBP
- Report
- November 2023
- 79 Pages
Global
From €4372EUR$4,950USD£3,781GBP
- Report
- September 2023
- 63 Pages
Asia Pacific
From €4372EUR$4,950USD£3,781GBP
- Report
- April 2023
- 57 Pages
Asia Pacific
From €4372EUR$4,950USD£3,781GBP
- Report
- April 2023
- 78 Pages
Global
From €4372EUR$4,950USD£3,781GBP
- Report
- December 2022
- 24 Pages
Global
From €2164EUR$2,450USD£1,872GBP
- Report
- June 2022
- 59 Pages
Global
- Report
- April 2022
- 64 Pages
Global
From €839EUR$950USD£726GBP
- Report
- February 2022
- 45 Pages
United States
From €2164EUR$2,450USD£1,872GBP
- Report
- December 2021
- 61 Pages
Global
From €4372EUR$4,950USD£3,781GBP
- Report
- September 2021
- 84 Pages
Global
From €4372EUR$4,950USD£3,781GBP
- Report
- September 2021
- 39 Pages
Global
- Report
- November 2020
- 63 Pages
Global
- Report
- November 2020
- 40 Pages
Global
From €4372EUR$4,950USD£3,781GBP
- Report
- August 2020
- 65 Pages
Global
From €4372EUR$4,950USD£3,781GBP
- Report
- August 2020
- 74 Pages
Global
From €2650EUR$3,000USD£2,292GBP
- Report
- April 2020
- 63 Pages
Global
- Report
- April 2020
- 65 Pages
Global

The COVID 19 Diagnostics market is a rapidly growing sector of the healthcare industry. It is focused on the development and production of tests and other diagnostic tools to detect the presence of the virus. These tests are used to identify individuals who have been infected with the virus, as well as those who may have been exposed to it. The market is also focused on the development of treatments and vaccines to combat the virus.
The Diagnostics market is driven by the need for rapid and accurate testing, as well as the need for treatments and vaccines. This has led to an increase in investment in the sector, as well as the development of new technologies and products.
Companies in the COVID 19 Diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more